Explain this page
Arphra AIPlain-English read on Greenwich LifeSciences, Inc.’s valuationEnterprise value
$338.1M
Market cap
$348.61M
Net debt
—
Total debt
—
Cash & ST inv.
—
Capital structure
· balance sheet · 2026-06-23Enterprise-value bridge
Market capitalisation$348.61M
+ Total debt+—
− Cash & short-term investments−—
= Enterprise value$338.1M
Valuation
· key metrics · TTMEV multiples
EV / EBITDA-15.5×
EV / Sales0.0×
EV / FCF-26.5×
Net debt / EBITDA0.5×
Debt / Equity—